ECSP12012356A - DERIVATIVES OF QUINOLIZIDINE AND INDOLIZIDINE - Google Patents

DERIVATIVES OF QUINOLIZIDINE AND INDOLIZIDINE

Info

Publication number
ECSP12012356A
ECSP12012356A ECSP12012356A ECSP12012356A EC SP12012356 A ECSP12012356 A EC SP12012356A EC SP12012356 A ECSP12012356 A EC SP12012356A EC SP12012356 A ECSP12012356 A EC SP12012356A
Authority
EC
Ecuador
Prior art keywords
glyt
compounds
lower alkyl
glycine
inhibitors
Prior art date
Application number
Other languages
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP12012356 priority Critical patent/ECSP12012356A/en
Publication of ECSP12012356A publication Critical patent/ECSP12012356A/en

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención, se refiere a compuestos de la fórmula general I-A ó I-B I-A y I-B en donde, X, es un enlace o un grupo -CH2, R1, R2 y R3 son, de una forma independiente, las unas con respecto a las otras, hidrógeno, alcoxi inferior, alquilo inferior sustituido por halógeno, ó S-alquilo inferior; o a sales de adición de ácidos, farmacéuticamente aceptables, a una mezcla racémica, o sus correspondientes enantiómeros y / o isómeros ópticos de éste.Se ha encontrado el hecho de que, los compuestos de las fórmulas generales I-A y I-B, son buenos inhibidores del transportador de glicina 1 (GlyT-1), y que éstos tienen una buena selectividad a los inhibidores del transportador de glicina 2 (GlyT-2), apropiados en el tratamiento de los trastornos neurológicos y neuropsiquiátricos.The present invention relates to compounds of the general formula IA or IB IA and IB wherein, X, is a bond or a group -CH2, R1, R2 and R3 are, independently, the ones with respect to the others, hydrogen, lower alkoxy, lower alkyl substituted by halogen, or S-lower alkyl; or to pharmaceutically acceptable acid addition salts, to a racemic mixture, or their corresponding enantiomers and / or optical isomers thereof. It has been found that the compounds of the general formulas IA and IB are good transporter inhibitors of glycine 1 (GlyT-1), and that these have a good selectivity to glycine transporter 2 inhibitors (GlyT-2), appropriate in the treatment of neurological and neuropsychiatric disorders.

ECSP12012356 2012-12-21 2012-12-21 DERIVATIVES OF QUINOLIZIDINE AND INDOLIZIDINE ECSP12012356A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP12012356 ECSP12012356A (en) 2012-12-21 2012-12-21 DERIVATIVES OF QUINOLIZIDINE AND INDOLIZIDINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP12012356 ECSP12012356A (en) 2012-12-21 2012-12-21 DERIVATIVES OF QUINOLIZIDINE AND INDOLIZIDINE

Publications (1)

Publication Number Publication Date
ECSP12012356A true ECSP12012356A (en) 2013-01-31

Family

ID=52634061

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP12012356 ECSP12012356A (en) 2012-12-21 2012-12-21 DERIVATIVES OF QUINOLIZIDINE AND INDOLIZIDINE

Country Status (1)

Country Link
EC (1) ECSP12012356A (en)

Similar Documents

Publication Publication Date Title
PE20160546A1 (en) BICYCLE PYRIDYL DERIVED COMPOUNDS FUSED TO RING AS INHIBITORS OF FGFR4
CL2018000036A1 (en) Ethynyl derivatives
CR20130371A (en) IMIDAZO [5,1-f] [1,2,4] TRIAZINS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
CU24327B1 (en) DERIVATIVES OF 1,4-BENZOTIAZEPIN, USEFUL TO TREAT DISORDERS AND DISEASES ASSOCIATED WITH RIANODINE RECEPTORS, AND THE PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM
CY1117773T1 (en) NEW HANDLING N-ACYL-5,6,7,8-SUBSTITUTES) -TETRAHYDRO- [1,2,4] TRIAZOLO [4,3-A] PYRAZINS AS OPTIONAL COMPONENTS OF 3-LIGHT LIGHTS USE IN NK-3 RELATED INTERFERENCE DISORDERS
UY35012A (en) ALCOXIPIRAZOLES AS SOLUBLE CYCLING GUANILATE ACTIVATORS
UY33557A (en) OXADIAZOL INHIBITORS OF LEUCOTRENE PRODUCTION
PE20151860A1 (en) DERIVATIVES OF 6- (5-HYDROXY-1H-PIRAZOL-1-IL) NICOTINAMIDE AND THEIR USE AS PHD INHIDERS
AR084011A1 (en) USEFUL HETEROCICLIC NITROGEN COMPOUNDS FOR THE TREATMENT OF INFECTIONS BY RESPIRATORY SYNCTIAL VIRUS (RSV), PROCESS TO PREPARE THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MX2015008233A (en) Novel quinolone derivatives.
AR085088A1 (en) INHIBITORS OF HISTONA DEACETILASE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EA201490272A1 (en) NEW 4-PIPERIDINYL COMPOUNDS FOR USE AS TANKIRASE INHIBITORS
PE20142081A1 (en) QUINURENIN-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF USE OF THEM
AR092555A1 (en) 2-OXO-2,3-DIHIDRO-INDOLES AND ITS USE FOR THE TREATMENT OF CNS DISORDERS
AR086036A1 (en) ETHYLLY DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF (mGluR5)
AR104331A1 (en) TETRAZOL DERIVATIVES
CR20130476A (en) DERIVATIVES OF PIRAZOLIDIN-3-ONA
AR105662A1 (en) DERIVATIVES OF PIRIDINE AND PYRIMIDINE AS INHIBITORS OF EAAT3
ECSP13012548A (en) OXADIAZOL INHIBITORS OF LEUCOTRENE PRODUCTION.
ECSP11011196A (en) PIPERIDINE DERIVATIVES
CO6630104A2 (en) Quinolizidine and indolizidine derivatives
CR20150158A (en) ETHYLLY DERIVATIVES AS MGLUR5 ACTIVITY RECEIVER MODULATORS
EA201692404A1 (en) PEPTIDES THAT PERFORM THE ROLE OF OXYTOCINE AGONISTS
CR20150143A (en) ETHYLLY DERIVATIVES AS MODULATORS OF THE MGLUR5 ACTIVITY RECEIVER
UA113223C2 (en) ARYLETINYLPYRIMIDINE